BWM
PRAX icon

Bernard Wealth Management’s Praxis Precision Medicines PRAX Stock Holding History

Bernard Wealth Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Buy
+181
New +$57.3K 0.02% 126

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bernard Wealth Management's PRAX Position: Q2 2026 in Review

Bernard Wealth Management opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 181 shares worth $60.6K. The stake represents 0.02% of the portfolio and ranks #126 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bernard Wealth Management held 181 shares of Praxis Precision Medicines worth $60.6K as of Q2 2026.
  • Praxis Precision Medicines was a new Bernard Wealth Management position in Q2 2026.
  • Praxis Precision Medicines made up 0.02% of Bernard Wealth Management's portfolio in Q2 2026, its #126 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bernard Wealth Management's 13F filing for Q2 2026, filed 21 Aug 2026.